Quantification pitfalls in comparative studies of antianginal therapies
- 1 April 1975
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 89 (4), 521-525
- https://doi.org/10.1016/0002-8703(75)90161-1
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Lidoflazine: Double-blind trial of a new coronary vasodilator in angina pectorisEuropean Journal of Clinical Pharmacology, 1973
- XVII. Synchronous partition and bivariate evaluation in predictive stratificationClinical Pharmacology & Therapeutics, 1972
- The medical treatment of angina pectoris II. Design of an antianginal drug studyAmerican Heart Journal, 1972
- XVI. The process of prognostic stratification (Part 2)Clinical Pharmacology & Therapeutics, 1972
- XV. The process of prognostic stratification (Part I)Clinical Pharmacology & Therapeutics, 1972
- XIV. The purposes of prognostic stratificationClinical Pharmacology & Therapeutics, 1972
- Angina Pectoris: Pathophysiology, Evaluation, and TreatmentAnnals of Internal Medicine, 1971
- Importance of the Design of an Exercise Protocol in the Evaluation of Patients with Angina PectorisCirculation, 1971
- ASSAY OF ANTIANGINAL AGENTS—THE RAPPORT PERIODJAMA, 1958
- CASES OF INOPERABLE CANCER TREATED WITH GOAT SERUMBMJ, 1915